About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Our impact
Suppliers
Our strategy
Our strategy
Neurodegeneration
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease research funding
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Therapeutics
Home
Licensing
Therapeutics
Print this list
All
Devices & Software
Diagnostics
Research Tools
Therapeutics
All
Cancer
Inflammation
Biotherapeutic
Enabling technologies
Cardiovascular and Respiratory system
Bioinformatics and Diagnostics
Research tools/Enabling technologies
Neuropathic Pain
Diagnostics
Alzheimer’s Disease
Cell line
Cardiovascular disease; osteolytic diseases /oncology
COVID-19/Coronavirus
Therapeutics
Anti-Netrin-1 humanised antibody for osteolytic bone disease
Cardiovascular disease; osteolytic diseases /oncology
Therapeutics
Copper-based nanoparticles for use as Antibacterials
Therapeutics
LITA: Liposome-acetate nanoparticle for the treatment of cancer
Cancer
Key Contact
Steven Tait
Senior Business Manager
+ 44 (0) 131 311 7024
Therapeutics
MIF inhibitors for the treatment of inflammation
Inflammation
Key Contact
Derek Sheader
Senior Business Development Manager
Therapeutics
GalR2 Agonists for the Treatment of Pain
Neuropathic Pain
Therapeutics
Beta amyloid-targeted therapeutic antibody
Alzheimer’s Disease
Key Contact
Kevin Buchan
Senior Business Development Manager
Therapeutics
Ang2 specific biotherapeutic
Biotherapeutic
Key Contact
Rachael Brooker
Senior Business Manager
+ 44 (0)131 460 3425
My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation